NovoCure Ltd
NVCR· Nasdaq
NVCRNovoCure Ltd
Filed Feb 22, 2018 · 10-K · 53 days after period end · 0001564590-18-002766
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $53.66M | $30.24M | $12.38M | — |
| Net Income | -$10.95M | -$22.17M | -$32.93M | — |
| EPS Diluted | -$0.12 | -$0.26 | -$0.39 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NovoCure Ltd · CIK 1645113 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Feb 22, 2018 · 53 d after period end
